Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 89

Similar articles for PubMed (Select 7713997)

1.

Local cerebral glucose utilization and cytoskeletal proteolysis as indices of evolving focal ischemic injury in core and penumbra.

Yao H, Ginsberg MD, Eveleth DD, LaManna JC, Watson BD, Alonso OF, Loor JY, Foreman JH, Busto R.

J Cereb Blood Flow Metab. 1995 May;15(3):398-408.

2.

Three-dimensional metabolic and hemodynamic imaging of the normal and ischemic rat brain.

Ginsberg MD, Back T, Zhao W.

Acta Neurochir Suppl. 1996;66:44-9.

PMID:
8780796
3.

Calcium-activated proteolysis in rat neocortex induced by transient focal ischemia.

Hong SC, Lanzino G, Goto Y, Kang SK, Schottler F, Kassell NF, Lee KS.

Brain Res. 1994 Oct 24;661(1-2):43-50.

PMID:
7834383
5.

SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection.

Legos JJ, Lenhard SC, Haimbach RE, Schaeffer TR, Bentley RG, McVey MJ, Chandra S, Irving EA, Andrew A Parsons, Barone FC.

Exp Neurol. 2008 Jul;212(1):53-62. doi: 10.1016/j.expneurol.2008.03.011. Epub 2008 Mar 25.

PMID:
18462720
6.

Hyperthermia enhances spectrin breakdown in transient focal cerebral ischemia.

Morimoto T, Ginsberg MD, Dietrich WD, Zhao W.

Brain Res. 1997 Jan 23;746(1-2):43-51.

PMID:
9037482
7.

Cross-talk between calpain and caspase-3 in penumbra and core during focal cerebral ischemia-reperfusion.

Sun M, Zhao Y, Xu C.

Cell Mol Neurobiol. 2008 Jan;28(1):71-85. Epub 2007 Dec 21.

PMID:
18157632
9.

The acute ischemic penumbra: topography, life span, and therapeutic response.

Ginsberg MD, Belayev L, Zhao W, Huh PW, Busto R.

Acta Neurochir Suppl. 1999;73:45-50.

PMID:
10494340
10.
11.

mu-calpain activation and calpain-mediated cytoskeletal proteolysis following traumatic brain injury.

Kampfl A, Posmantur R, Nixon R, Grynspan F, Zhao X, Liu SJ, Newcomb JK, Clifton GL, Hayes RL.

J Neurochem. 1996 Oct;67(4):1575-83.

PMID:
8858942
13.

Glutamate receptor antagonists inhibit calpain-mediated cytoskeletal proteolysis in focal cerebral ischemia.

Minger SL, Geddes JW, Holtz ML, Craddock SD, Whiteheart SW, Siman RG, Pettigrew LC.

Brain Res. 1998 Nov 9;810(1-2):181-99.

PMID:
9813316
14.
15.

Immunohistochemical study of calpain-mediated breakdown products to alpha-spectrin following controlled cortical impact injury in the rat.

Newcomb JK, Kampfl A, Posmantur RM, Zhao X, Pike BR, Liu SJ, Clifton GL, Hayes RL.

J Neurotrauma. 1997 Jun;14(6):369-83.

PMID:
9219852
16.

Prolonged calpain-mediated spectrin breakdown occurs regionally following experimental brain injury in the rat.

Saatman KE, Bozyczko-Coyne D, Marcy V, Siman R, McIntosh TK.

J Neuropathol Exp Neurol. 1996 Jul;55(7):850-60.

PMID:
8965100
17.

DNA fragmentation in ischemic core and penumbra in focal cerebral ischemia in rats.

Yao H, Takasawa R, Fukuda K, Shiokawa D, Sadanaga-Akiyoshi F, Ibayashi S, Tanuma S, Uchimura H.

Brain Res Mol Brain Res. 2001 Jul 13;91(1-2):112-8.

PMID:
11457498
18.

Human copper-zinc superoxide dismutase transgenic mice are highly resistant to reperfusion injury after focal cerebral ischemia.

Yang G, Chan PH, Chen J, Carlson E, Chen SF, Weinstein P, Epstein CJ, Kamii H.

Stroke. 1994 Jan;25(1):165-70.

PMID:
8266365
19.

Time-related neuronal changes following middle cerebral artery occlusion: implications for therapeutic intervention and the role of calpain.

Bartus RT, Dean RL, Cavanaugh K, Eveleth D, Carriero DL, Lynch G.

J Cereb Blood Flow Metab. 1995 Nov;15(6):969-79.

20.

Differential hydroxylation of salicylate in core and penumbra regions during focal reversible cerebral ischemia.

Solenski NJ, Kwan AL, Yanamoto H, Bennett JP, Kassell NF, Lee KS.

Stroke. 1997 Dec;28(12):2545-51; discussion 2551-2.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk